Verici DX Logo

Media

NewsMedia

Update re. potential demerger of FractalDx and distribution in specie

April 28, 2020
Download full announcement Proposed capital reduction and notice of General Meeting Renalytix AI plc (LSE: RENX), the AIM-traded developer of clinical grade artificial intelligence in vitro diagnostics for kidney disease, announces that a circular (a “Circular”) will today be sent to shareholders providing background to, details of and reasons for, a proposed Capital Reduction and Distribution in Specie, to […]
Keep Reading
1 6 7 8
crossmenuchevron-down